Sonnet Biotherapeutc Hldng I
13F holders, Q2 2024 (June 30)11holders +1
4new positions
3sold out
$0.94avg. 13F price*
At the end of Q2 2024, 11 institutions reported holding Sonnet Biotherapeutc Hldng I in their 13F filings, up 1 from Q1 2024. 4 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($255K), Sabby Management, LLC ($223K) and Virtu Financial LLC ($31K).
- Company
- Sonnet Biotherapeutc Hldng I
- CUSIP
- 83548R303
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $498K |
| Exits | 3 | $64K |
All 13F filers, Q1 2024 → Q2 2024: 557,410 shares bought and 34,515 shares sold, net +522,895 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Armistice Capital, LLC | 0.01% | New | 272,000 | $255K |
| Sabby Management, LLC | 3.33% | New | 238,395 | $223K |
| Virtu Financial LLC | 0.00% | Add +201.5% | 32,687 | $31K |
| Geode Capital Management, LLC | 0.00% | New | 16,704 | $16K |
| Vanguard Group Inc. | 0.00% | No change | 14,726 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +163.3% | 7,171 | $7K |
| UBS Group AG | 0.00% | New | 3,997 | $4K |
| BlackRock Inc. | 0.00% | No change | 520 | $488 |
| Bank of America Corp. | 0.00% | Add +366.7% | 28 | $27 |
| Morgan Stanley | 0.00% | Reduce -33.3% | 4 | $4 |
| Private Wealth Management Group, LLC | 0.00% | No change | 3 | $3 |
"% of holder's portfolio" is SONNET BIOTHERAPEUTC HLDNG I's weight in each manager's 13F, not the share of Sonnet Biotherapeutc Hldng I the manager owns.